Mutagen-specific mutation signature determines global microRNA binding.

Strikingly, Pita program [39] predicted a highly significant global miRNA binding preference to the reference genomic sequence over the mutated sequence (p = 2.5×10 −6 ) in the melanoma patient genome, independently of the exact ΔΔG threshold chosen to define binding ( Figure 1A ).

also in 132,142 other papers